{"id":1201,"date":"2013-09-18T17:30:31","date_gmt":"2013-09-18T17:30:31","guid":{"rendered":"https:\/\/palladiumcapital.com\/?p=1201"},"modified":"2013-10-09T14:37:37","modified_gmt":"2013-10-09T14:37:37","slug":"palladium-capital-advisors-exclusive-agent-for-plc-systems-1750000-equity-raise","status":"publish","type":"post","link":"https:\/\/www.palladiumcapital.com\/palladium-capital-advisors-exclusive-agent-for-plc-systems-1750000-equity-raise\/","title":{"rendered":"Palladium Capital Advisors Exclusive Agent for PLC Systems’ $1,750,000 Equity Raise"},"content":{"rendered":"

\"PLC<\/a><\/p>\n

 <\/p>\n

New York, NY, September 18, 2013 – Palladium Capital Advisors today announced it served as the exclusive placement agent for PLC Systems Inc. $1.75 million capital raise.<\/p>\n

 <\/p>\n

PLC Systems Inc is a company focused on innovative medical device technologies. It has raised $1.75 million in gross proceeds through the sale of 29,166,668 shares of common stock at a purchase price of $0.06 per share and five-year warrants to purchase 29,166,668 shares of common stock at an exercise price of $0.08 per share.\u00a0PLC Systems plans to use the proceeds from this financing to fund the ongoing U.S. pivotal trial with RenalGuard\u00ae<\/sup>\u00a0during imaging procedures and for general corporate purposes.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

  New York, NY, September 18, 2013 – Palladium Capital Advisors today announced it served as the exclusive placement agent for PLC Systems Inc. $1.75 million capital raise.   PLC Systems Inc is a company focused on innovative medical device technologies. It has raised $1.75 million in gross proceeds through the sale of 29,166,668 shares […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"_links":{"self":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts\/1201"}],"collection":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/comments?post=1201"}],"version-history":[{"count":0,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts\/1201\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/media?parent=1201"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/categories?post=1201"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/tags?post=1201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}